Uni-Bio科学集团通过批准新的科林敷料和启动皮肤护理产品,实现了重要里程碑。 Uni-Bio Science Group achieves key milestones with a new collagen dressing approval and a skincare product launch.
Uni-Bio科学集团在医学美学市场取得了两大里程碑。 Uni-Bio Science Group has achieved two major milestones in the medical aesthetics market. 该公司获得批准,将其重新组合的科拉根敷料作为二级医疗装置,并推出了一种新的医学美学产品,即 " " 。 The company received approval for its recombinant collagen dressing as a Class II medical device and launched "肌顏態®," a new medical aesthetics product. 这些旨在提高皮肤质量和维修的革新措施吸引了皮肤学家的注意,反映了该公司对革新和市场增长的承诺。 These innovations, which aim to enhance skin quality and repair, have garnered attention from dermatologists and reflect the company's commitment to innovation and market growth. 预计到2030年,医学美学市场的价值将超过6 000亿元人民币。 The medical aesthetics market is projected to be worth over RMB 600 billion by 2030.